top of page

IMMUNOTHERAPY

The Future of Medicine

Antiviral Immunotherapy  

Pioneering Immunotherapy for Viral & Oncology Indications 

ANTIVIRAL IMMUNOTHERAPY

Immunotherapy is 21st century medicine.    Immunacor harnesses the innate immune response to mitigate viral load & increase adaptive immunity.   Immunacor enters Phase 1 clinical trials Q3-Q4 2020.   

ONCOLOGY 

Immuno-oncology is at the forefront of cancer therapy.  Immunacor's immunotherapy can activate the immune system against cancer and will be entering Phase 1  Clinical Trials Q1 2021.  

bottom of page